SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Allos Therapeutics, Inc. (ALTH)
An SI Board Since July 2002
Posts SubjectMarks Bans Symbol
226 18 0 ALTH
Emcee:  Arthur Radley Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
226Hmmmm.....and now it's around $2 a share. Perhaps someone can tell me what hChris08-6/21/2011
225Good call, as it got pretty close to your target this April. Did you take some tuck-7/20/2010
224[t]ALTH[/t] has been basing nicely around $6, and in my opinion, is about to movMike Maxton-12/19/2009
223Allos Therapeutics Announces FDA Advisory Committee Recommends Accelerated Approkenhott-9/3/2009
222It looks like the filed sale is in connection with a 10b5-1 plan, so maybe not sidos-9/1/2009
221FWIW insiders sold substantial amounts of shares earlier this month. Kind of slirkrw-8/28/2009
220My bad. Briefing docs are already out: fda.gov Explains the wide swing in prituck-8/28/2009
219Briefing docs are already out, Sep 2nd, Onco. Adv. Cmt. Don't have a quick kenhott-8/28/2009
218So the PDUFA date for PDX in PTCL is 9/24/2009. Yet the OI in Allos options is tuck-8/28/2009
217Allos: 27% of Patients Respond to Pralatrexate Adam Feuerstein 12/07/08 - 05:3Doc Bones-12/8/2008
216Don't care for the reduction in RR?keokalani'nui-5/16/2008
215I am out. No joke about being out of my mind, etc.kenhott-5/16/2008
214Indication and need are the reasons for the trial design. Total enrollment overkenhott-4/23/2008
213I haven't followed this closely, but . . . it sure is a good thing thtuck-4/22/2008
212Allos Therapeutics Completes Patient Enrollment in Pivotal Phase 2 PROPEL Trial kenhott-4/22/2008
211Allos Therapeutics Initiates Phase 2b Study of PDX in Patients With Non-small Cekenhott-1/7/2008
210I noticed that the posters were basically unreadable. Email Allos and they willkenhott-12/12/2007
209Great Post kenhott! Tell me some moretronitup-12/11/2007
208ALTH 8k 10/25/07 sec.gov On October 25, 2007, Allos Therapeutics, Inc.’s (the kenhott-12/7/2007
207Interim Response and Safety Analyses Support Continuation of Allos Therapeutics&kenhott-9/26/2007
206Allos article from MF (5-21-07) - >>> Allos Aligned for Success fool.cgfp927-6/7/2007
205alth going 9% down now in large vol and no news.idos-9/14/2006
20409:44 am Allos Therapeutics: Needham & Co upgrades Buy to Strong Buy. TargetIan@SI-9/6/2006
203Allos Therapeutics Receives Special Protocol Assessment for Pivotal Phase 2 StudLJM-8/2/2006
202Here's the chart I was talking about, with just a few random holdings thrownFiloF-7/27/2006
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News